BlackRock’s Applied Genetic Technologies Corporation AGTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-918,381
| Closed | -$249K | – | 5936 |
|
|
2022
Q3 | $249K | Sell |
918,381
-5,564
| -0.6% | -$2.43K | ﹤0.01% | 4919 |
|
|
2022
Q2 | $711K | Sell |
923,945
-194,380
| -17% | -$173K | ﹤0.01% | 4660 |
|
|
2022
Q1 | $1.2M | Buy |
1,118,325
+12,375
| +1% | +$22.5K | ﹤0.01% | 4602 |
|
|
2021
Q4 | $2.1M | Buy |
1,105,950
+66,771
| +6% | +$160K | ﹤0.01% | 4382 |
|
|
2021
Q3 | $3.13M | Buy |
1,039,179
+2,407
| +0.2% | +$8.57K | ﹤0.01% | 4142 |
|
|
2021
Q2 | $4.05M | Sell |
1,036,772
-1,952,840
| -65% | -$8.1M | ﹤0.01% | 3969 |
|
|
2021
Q1 | $15.2M | Buy |
2,989,612
+1,257,545
| +73% | +$6.52M | ﹤0.01% | 3332 |
|
|
2020
Q4 | $7.08M | Buy |
1,732,067
+114,221
| +7% | +$561K | ﹤0.01% | 3541 |
|
|
2020
Q3 | $7.86M | Buy |
1,617,846
+20,727
| +1% | +$113K | ﹤0.01% | 3361 |
|
|
2020
Q2 | $8.85M | Buy |
1,597,119
+1,158,972
| +265% | +$5.31M | ﹤0.01% | 3254 |
|
|
2020
Q1 | $1.44M | Buy |
438,147
+179,072
| +69% | +$944K | ﹤0.01% | 3753 |
|
|
2019
Q4 | $1.17M | Sell |
259,075
-38,856
| -13% | -$123K | ﹤0.01% | 3956 |
|
|
2019
Q3 | $1.24M | Sell |
297,931
-13,010
| -4% | -$47K | ﹤0.01% | 3901 |
|
|
2019
Q2 | $1.18M | Buy |
310,941
+28,429
| +10% | +$117K | ﹤0.01% | 3958 |
|
|
2019
Q1 | $1.18M | Sell |
282,512
-25,019
| -8% | -$87.4K | ﹤0.01% | 3861 |
|
|
2018
Q4 | $765K | Sell |
307,531
-19,456
| -6% | -$114K | ﹤0.01% | 3979 |
|
|
2018
Q3 | $2.39M | Sell |
326,987
-5,514
| -2% | -$24.1K | ﹤0.01% | 3717 |
|
|
2018
Q2 | $1.23M | Sell |
332,501
-51,189
| -13% | -$237K | ﹤0.01% | 3878 |
|
|
2018
Q1 | $1.48M | Sell |
383,690
-78,427
| -17% | -$330K | ﹤0.01% | 3776 |
|
|
2017
Q4 | $1.66M | Sell |
462,117
-56,064
| -11% | -$212K | ﹤0.01% | 3750 |
|
|
2017
Q3 | $2.05M | Buy |
518,181
+55,539
| +12% | +$255K | ﹤0.01% | 3701 |
|
|
2017
Q2 | $2.36M | Sell |
462,642
-544,731
| -54% | -$3.06M | ﹤0.01% | 3647 |
|
|
2017
Q1 | $6.95M | Buy |
1,007,373
+997,447
| +10,049% | +$7.79M | ﹤0.01% | 3271 |
|
|
2016
Q4 | $93K | Buy |
9,926
+1,001
| +11% | +$9.02K | ﹤0.01% | 2593 |
|
|
2016
Q3 | $87K | Buy |
8,925
+277
| +3% | +$3.74K | ﹤0.01% | 2685 |
|
|
2016
Q2 | $122K | Buy |
8,648
+7,431
| +611% | +$116K | ﹤0.01% | 2414 |
|
|
2016
Q1 | $17K | Sell |
1,217
-783
| -39% | -$11.5K | ﹤0.01% | 2935 |
|
|
2015
Q4 | $41K | Buy |
+2,000
| New | +$30.9K | ﹤0.01% | 2178 |
|
BlackRock's AGTC Position: Q4 2022 in Review
BlackRock sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2022, closing a stake of 918,381 shares — an estimated $249K sold.
BlackRock first reported a position in AGTC in Q4 2015 and held it in 28 quarters. The position peaked at $15.2M in Q1 2021. 0 funds tracked by Wall St. Rank hold AGTC as of Q4 2022.
- BlackRock reported no remaining Applied Genetic Technologies Corporation position as of Q4 2022 after selling out during the quarter.
- BlackRock sold 918,381 Applied Genetic Technologies Corporation shares in Q4 2022, an estimated $249K.
- BlackRock first reported a position in Applied Genetic Technologies Corporation in Q4 2015 and held it in 28 quarters.
- BlackRock's Applied Genetic Technologies Corporation position peaked at $15.2M in Q1 2021.
- 0 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2022.
Based on BlackRock's 13F filing for Q4 2022, filed 13 Feb 2023.